University of Missouri-Kansas City School of Medicine Cardiovascular Disease

Topics

• Cardiac Imaging and Diagnostics 336
• Coronary Interventions and Diagnostics 267
• Cardiac Valve Diseases and Treatments 242
• Heart Failure Treatment and Management 230
• Cardiac Arrest and Resuscitation 199
• Acute Myocardial Infarction Research 183
• Atrial Fibrillation Management and Outcomes 168
• Cardiac Health and Mental Health 140
• Mechanical Circulatory Support Devices 108
• Cardiac pacing and defibrillation studies 88
• Amyloidosis: Diagnosis, Treatment, Outcomes 84
• Lipoproteins and Cardiovascular Health 84

Most cited

1. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.

   Circulation · 2023 · 1,349 citations · Suzanne Arnold

2. Transcatheter Aortic-Valve Replacement for Asymptomatic Severe Aortic Stenosis.

   The New England journal of medicine · 2025 · 240 citations · Adnan Chhatriwalla

3. The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial.

   Nature medicine · 2022 · 758 citations · Michael Nassif

4. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.

   Journal of the American College of Cardiology · 2023 · 484 citations · Suzanne Arnold

5. Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy.

   The New England journal of medicine · 2024 · 266 citations · Michael Nassif, John Spertus

6. The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial.